Bergenin Attenuates Hepatic Fibrosis by Regulating Autophagy Mediated by the PPAR-γ/TGF-β Pathway

Yujing Xia1, Jingjing Li1, Kan Chen1

  • 1Department of Gastroenterology, Shanghai Tenth People's Hospital, School of Clinical Medicine of Nanjing Medical University, Shanghai 200072, China.

PPAR Research
|January 25, 2021
PubMed

Insights

Bergenin shows promise for treating liver fibrosis by reducing liver injury and extracellular matrix deposition. This study found bergenin effectively inhibited key fibrotic pathways and autophagy.

Area of Science:

  • Hepatology and Pharmacology
  • Molecular Biology

Background:

  • Liver fibrosis, characterized by excessive extracellular matrix (ECM) deposition, is a hallmark of chronic liver diseases like cirrhosis.
  • Current treatments for liver fibrosis are limited, necessitating the development of novel therapeutic agents.

Purpose of the Study:

  • To investigate the potential protective effects of bergenin against liver fibrosis induced by carbon tetrachloride and bile duct ligation.
  • To elucidate the molecular mechanisms underlying bergenin's action on liver fibrosis, including its impact on autophagy and the TGF-β pathway.

Main Methods:

  • Induction of liver fibrosis models using carbon tetrachloride and bile duct ligation in relevant study subjects.
  • Quantitative real-time PCR (qRT-PCR), western blotting, and immunohistochemistry were utilized to assess hepatocyte injury and ECM formation.
  • Analysis of autophagy markers and the transforming growth factor-beta (TGF-β) signaling pathway.

Main Results:

  • Bergenin demonstrated a dose-dependent reduction in hepatocyte injury and ECM accumulation in the induced liver fibrosis models.
  • Bergenin treatment led to the activation of peroxisome proliferator-activated receptor-gamma (PPAR-γ).
  • Bergenin effectively inhibited the TGF-β pathway and autophagy, key contributors to liver fibrosis progression.

Conclusions:

  • Bergenin exhibits significant hepatoprotective effects against induced liver fibrosis.
  • The mechanism involves the activation of PPAR-γ, inhibition of the TGF-β pathway, and suppression of autophagy.
  • Bergenin represents a potential therapeutic candidate for managing liver fibrosis and related chronic liver diseases.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
9.1K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
8.8K
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
3.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.7K
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.3K